GlaxoSmithKline said it would temporarily withdraw its application to expand use of Avodart--which is approved to treat symptoms of an enlarged prostate--to include cancer prevention. Report [1]
Links:
[1] http://www.nj.com/business/index.ssf/2009/11/glaxosmithkline_pulls_applicat.html